| Target Price | $5.10 |
| Price | $1.47 |
| Potential |
246.94%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Prelude Therapeutics Inc 2026 .
The average Prelude Therapeutics Inc target price is $5.10.
This is
246.94%
register free of charge
$5.25
257.14%
register free of charge
$3.03
106.12%
register free of charge
|
|
| A rating was issued by 10 analysts: 8 Analysts recommend Prelude Therapeutics Inc to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Prelude Therapeutics Inc stock has an average upside potential 2026 of
246.94%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 23 2025 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Aug 18 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 05 2025 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
| Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 23 2025 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Aug 18 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 05 2025 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Apr 29 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 08 2025 |
|
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Mar 12 2025 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Dec 11 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


